Form 8-K BRISTOL MYERS SQUIBB CO For: Oct 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Bristol-Myers Squibb Co. (BMY) PT Raised to $55 at Leerink Partners
November 4, 2024 6:20 AM ESTLeerink Partners analyst David Risinger raised the price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $55.00 (from $53.00) while maintaining a Market Perform rating.
The analyst comments "Bottom line. We are increasing our PT from $53 (7.5x old 25E EPS of $7.06) to $55 (7.5x new 25E... More
